Use of avexitide in patients with post-bariatric hypoglycaemia and hyperinsulinemic hypoglycaemiaPhase 2b results of avexitide (Eiger BioPharmaceuticals) in patients with post-bariatric hypoglycemia (PBH) and hyperinsulinemic...
LSG and RYGB-induced upregulation of apoA-IV is beneficial for insulin secretion and energy expenditure5 days ago
Tirzepatide reduced sleep apnoea severity by up to nearly two-thirds in adults living with OSA and obesity5 days ago